|
contents | asia | ||||
| Canon U.S. At Microtas2006 In Tokyo Canon U.S.A., Inc., announced that Canon U.S. Life Sciences, Inc., is using Caliper Life Sciences' LabChip microfluidics technology and industry techniques in an effort to help develop future genetic diagnostic and screening solutions. Information will be presented at the 10th International Conference on Miniaturized Systems for Chemistry and Life Sciences in Tokyo, November 6th – 9th. Canon U.S. Life Sciences is seeking to leverage Caliper's microfluidics technology and industry thermal melting analysis techniques to shorten the processing time, lower the cost of gene diagnosis, and enable rapid review of genes in clinical environments. The microfluidics technology is based on the manipulation of nanoliter size volumes of patient samples to amplify genes, and the thermal melting analysis techniques use thermal energy to identify small differences in specific genes. The combination of these technologies is expected to offer the opportunity to create gene diagnosis and screening instruments that are more precise than current methods. write your comments about the article :: © 2006 Exhibition News :: home page |